U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07448363) titled 'Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica' on Feb. 26.
Brief Summary: The goal of this observational registry is to characterize the clinical features, severity, treatments, and outcomes of patients with atopic dermatitis in Costa Rica receiving systemic and advanced therapies in routine clinical practice. The main questions it aims to answer are:
What are the demographic and clinical characteristics of patients with moderate-to-severe atopic dermatitis treated in specialized dermatology centers in Costa Rica?
What treatments are used in real-world practice and how do they impact disease severity an...